We have observed
12 EP applications
Andrew John Sanderson
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after December 10, 2014).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Detoxified Escherichia coli immunogens
SALMONELLA CONJUGATE VACCINES
VIRION-LIKE DELIVERY PARTICLES FOR SELF-REPLICATING RNA MOLECULES
OUTER MEMBRANE VESICLES
OIL-IN-WATER EMULSIONS THAT CONTAIN NUCLEIC ACIDS
CATIONIC OIL-IN-WATER EMULSIONS
PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA
nOMV-ANTIGEN CONJUGATES AND USE THEREOF